| Name | Nedometinib |
|---|
| Description | Nedometinib is a tyrosine kinase inhibitor targeting to MEK1. Nedometinib has antineoplastic effect and can be used for research in dermatosis, cutaneous fibroneuroma, neurofibromatosis[1]. |
|---|---|
| Related Catalog | |
| Target |
MEK1[1] |
| References |
| Molecular Formula | C17H16FIN4O3 |
|---|---|
| Molecular Weight | 470.24 |